当前位置: 首页 > 详情页

Research on the visual quality contrast after WG-QO-LASEK and WG-SBK for the correction of high myopia

| 导出 |

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Fujian Provincial-Level Authorities Hospital, Fuzhou 350003, Fujian Province, China [2]The First Affiliated Hospital of Fujian Medical University, Fuzhou 350004, Fujian Province, China
出处:
ISSN:

关键词: Wavefront-aberration LASEK SBK higher-order aberrations NEI RQL-42

摘要:
Objective: To observe the visual quality contrast after WG-QO-LASEK and WG-SBK for the correction of high myopia. Method: We carried out the retrospective analysis of pre- and post operative clinical data of 40 cases (80 eyes) that have gone through WG-QO-LASEK and WG-SBK in the department of ophthalmology in our hospital. All patients were required to take preoperative and postoperative examinations including UCVA, BCVA, posterior corneal surface height, WaveScan aberrometer test and so on. And they filled in the NEI RQL-42 table. Results: There was no presence of severe postoperative complications. Each period, there was no significant difference in two groups of patients with uncorrected visual acuity, higher order aberrations. The total high order aberration, spherical aberration and coma were higher in WG-QO-LASEK group than those in WG-SBK group on first month and third months (P<0.05). two groups had no significant difference between the high order aberration, refractive error of quality of life scale NEI RQL-42 after operation between two groups were increased significantly. And the two groups of postoperative subjective visual quality indices were no significant differences. Conclusions: WG-QO-LASEK and WG-SBK in the treatment of myopia have effective prediction, accuracy and safety. On the early days after treatment, the total high order aberration, spherical aberration and coma in WG-QO-LASEK group were higher than WG-SBK group, but after six months, there was no significant difference between the two groups.

基金:
语种:
WOS:
中科院(CAS)分区:
出版当年[2015]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验
最新[2023]版:
JCR分区:
出版当年[2014]版:
Q4 MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版:
Q4 MEDICINE, RESEARCH & EXPERIMENTAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2014版] 出版当年五年平均 出版前一年[2013版] 出版后一年[2015版]

第一作者:
第一作者机构: [1]Fujian Provincial-Level Authorities Hospital, Fuzhou 350003, Fujian Province, China
通讯作者:
通讯机构: [*1]The First Affiliated Hospital of Fujian Medical University, Xuanwu Hospital of China Capital Medical University, No. 45, Changchun Street, Xicheng District, Beijing 100053, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院